.After F2G's 1st attempt to obtain a brand-new course of antifungal to market was derailed by the FD...
.Moderna has vowed to cut R&D spending through $1.1 billion through 2027. The selection to retrac...
.Only 4 months after Sanofi bet $80 million in beforehand money on Fulcrum Therapies' losmapimod, th...
.Cancer cells firm Oncternal Therapies is folding all its professional trials and also laying off pe...
.Roche is holding out hopes that its injectable weight problems possibility could eventually illustr...
.Novo Nordisk has actually raised the top on a phase 1 trial of its own dental amylin and also GLP-1...
.Only a few short weeks after gaining an FDA Fast Track tag for its investigational BTK degrader in ...
.Shortly after a positive information reduce for Eli Lilly's efsitora alfa, the Indianapolis-based b...
.BridgeBio Pharma is actually lowering its genetics therapy finances as well as pulling back coming ...
.GSK's try to cultivate the 1st injection for genital herpes simplex virus (HSV) has finished in fai...